Researchers Published Porcine SCID Model Dataset

The newly released multi-omic dataset offers a detailed look at a genetically engineered porcine model of immunodeficiency.

Updated on Sept. 22, 2026 in Life Sciences

Isometric editorial illustration featuring a DNA helix and a simplified pig head silhouette in muted teal and oxblood colors.
Researchers released a new multi-omic dataset for a RAG2-deficient porcine model, providing standardized genetic profiles to advance severe combined immunodeficiency research. AI Illustration. Upload story photo >

Scientists have released a comprehensive multi-omic dataset for a RAG2-deficient porcine model of severe combined immunodeficiency (SCID). This resource provides detailed genetic and cellular profiles to aid in the study of immune system development.

Why it matters

This dataset offers a critical foundation for researchers to study SCID pathophysiology and establish benchmarks for evaluating future therapeutic interventions. By providing standardized data, it helps improve the reproducibility and precision of immunological research.

The dataset utilizes TALEN-mediated editing to induce a p.His109del mutation in the RAG2 gene, resulting in thymic aplasia. Researchers verified the model using genomic sequencing, flow cytometry, RNA-seq, and ChIP-seq for H3K4me3 modifications.

The players

RAG2 Gene

This gene is essential for the initiation of V(D)J recombination, a process necessary for the development of mature B and T lymphocytes.

The details

The study successfully created the RAG2-deficient porcine model, confirming the absence of mature adaptive lymphocytes through flow cytometry and histopathological imaging. This collection of genomic and transcriptomic data provides a high-resolution map of immune failure in the model.

Timeline

  1. September 22, 2026: The research article was published online.

The Big Picture

This release shifts the paradigm of immunodeficiency research by moving beyond simple observational studies to a robust, multi-omic platform. It bridges the gap between basic genetics and therapeutic benchmarking, unlocking new potential for pre-clinical evaluation of gene-editing tools.

While primarily a research tool, this development could accelerate the path toward safer human gene-editing therapies by providing a more accurate testing environment. Future medical breakthroughs in treating rare immune disorders may rely on the data standards established by this model.

The takeaway

The publication of this dataset underscores the growing importance of transparent, high-depth genomic data in modern veterinary and medical research. Establishing standardized models is a critical step for scientists aiming to translate lab findings into effective clinical treatments.

Further reading

Explore more developments in the field by visiting our Life Sciences section.

Source note: This article includes information reported by Nature.